ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts.

Paul M Barr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.